Risk factors of death among children with Dengue Hemorrhagic fever

##plugins.themes.academic_pro.article.main##

Herry D Nawing
Nini Meutia Pelupessy
Merry Sabir
Husein Albar

Abstract

Background: Dengue hemorrhagic fever (DHF) is still periodically around developing countries including Indonesia. Morbidity and mortality of DHF can be reduced if early diagnosis and appropriate management.


Objective: Our study evaluate risk factors of death in pediatric DHF patients hospitalized in Wahidin Sudirohusodo Hospital Makassar.


Methods:  we review the medical records of patients aged ≤ 18 years from January 2016 to December 2018 with confirmed DHF  based on WHO criteria and serologically positive anti-dengue Ig M or positive anti-dengue IgM and Ig G.


Results: During the study period, 70 patients aged 1-17 years with the complete medical records enrolled in this study.  The DHF severity consisted of 37 cases (52,9%) with shock(DSS) and 33 cases (41,7%) without shock and  mostly of them was  admitted to the hospital on > 3 days of fever (63 cases /90,0%). Boys were predominantly (39/55,7%) found than girls (31/44,3%) and the majority of cases above 5 years (50/71,4%) with well-nourished patients in 46 cases (65,7%).  The hematocrit level ≥ 40 mg/dl, platelets ≤ 40.000/mm3, and leukocyte ≤ 4000 mm3/l were observed in 41 cases (58,6%), 36 cases (51,4%), and  48 cases (68,6%); respectively. Death was observed in four girls (5.7%) (p 0,034/OR 1,148/ 95% CI 1,003 - 1,315) with DSS because of  severe condition on admission.


Conclusions: Girl was an  independent risk factor of death among children with DHF. 


 

##plugins.themes.academic_pro.article.details##

References

1. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7–16.
2. Huy R, Buchy P, ConanA, Ngan C, Ong S, Ali R, Duong V, Yit S, Ung S,Te V, et al. National dengue surveillance in Cambodia 1980-2008: epidemiological and virological trends and the impact of vector control. Bull World Health Organ. 2010;88(9):650–7.
3. Sam SS, Omar SF, Teoh BT, Abd-Jamil J, AbuBakar S. Review of dengue
hemorrhagic fever fatal cases seen among adults: a retrospective study. PLoS Negl Trop Dis. 2013;7(5):e2194.
4. WHO. Regional Office for South-East Asia. Comprehensive guidelines for
prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded edition. New Delhi. India. SEARO Technical Publication Series No. 60. ISBN. 978-92-9022-387-0. 2011
5. World Health Organization, Regional Office for South-East Asia. Country reports: Bhutan and Timor- Leste. New Delhi: WHO-SEARO. 2004.
6. Pandey BD, Rai SK, Morita K KuraneI. First case of dengue virus in Techu in Nepal. Nepal Coll. J. 2004 Dec; 6(2): 157–159.
7. Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shearer FM, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel W, et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife. 2015;4:e08347.
8. Kusriastuti R, Sutomo S. Evolution of dengue prevention and control programme in Indonesia. Dengue Bull. 2005;29:1–7.
9. Harapan H, Michie A, Mudatsir M, Sasmono RT, Imrie A. Epidemiology of
dengue hemorrhagic fever in Indonesia: analysis of five decades data from the National Disease Surveillance. MC Res Notes. 2019; 2-6 12:350 https://doi.org/10.1186/s13104-019-4379-9.
10. WHO. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. Geneva, Switzerland: World Health Organisation .1997
11. WHO: Dengue Guildelines for Diagnosis, Prevention and Control. New edition. Geneva, Switzerland: World Health Organisation. 2009.
12. Nimmannitya S, Kalayanarooj S, Vitayasuporn A. Guideline for diagnosis and treatment of dengue haemorrhagic fever. Bangkok: Ministry of Public Health; 1999).
13. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, et al.(1989) An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 40: 418–427.
14. WHO. The WHO child growth standards 2006. (cited 2020Macr 20). Available from:https://www.who.int.childgrowth/en/.
15. Faridi MA, Aggarwal A, Kumar M, et al. Clinical and biochemical profile of
dengue haemorrhagic fever in children in Delhi. Trop Doct. 2008;38(1): 28-30.
16. Sahana KS, Sujatha R. Clinical profile of dengue among children according to
revised WHO classification: analysis of a 2012 outbreak from Southern India. Indian J Pediatr 2015;82:109-13.
17. Athira PP, Jagan OP, Umadevi P, Pragnatha K, Veena MN. A Retrospective
Study of Paediatric Dengue Cases in a Tertiary Care Hospital in Southern India. Journal of Clinical and Diagnostic Research. 2018 Jul, Vol-12(7): 1-6.
18. Aggarwal A, Chandra J, Aneja S, et al. An epidemic of dengue hemorrhagic fever and dengue shock syndorme in children in Delhi. Indian Pediatr. 1998;35(8):727- 32 .
19. Mittal H, Faridi MM, Arora SK, Patil R. Clinicohematological profile and platelet trends in children with dengue during 2010 epidemic in north India. Indian J Pediatr. 2012;79:467-71.
20. Kuno G, Gómez I, Gubler DJ. Detecting artificial anti-dengue IgM immune
complexes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1987;36:153–159.
21. Narayanan M, Aravind MA, Thilothammal N, Prema R, Sargunam CS,
Ramamurty N. Dengue fever epidemic in Chennai - a study of clinical profile and outcome. Indian Pediatr. 2002;39:1027-33
22. Dhooria GS, Bhat D, Bains HS. Clinical Profile and Outcome in Children of
Dengue Hemorrhagic Fever in North India . Iran J Pediatr, Sep 2008; Vol 18 ( o 3), Pp:222-228.
23. Ahmed S, Arif F, Yahya Y, et al. Dengue fever outbreak in Karachi 2006 - a
study of profile and outcome of children under 15 years of age. J Pak Med Assoc. 2008;58(1): 4-8.